Skip to main content
. 2011 Mar 23;2011:327923. doi: 10.4061/2011/327923

Figure 10.

Figure 10

Akt3 synergizes with V600EB-Raf in melanomas. UACC 903 cells transfected with siRNA targeting Akt3 and V600EB-Raf alone and in combination were subcutaneously injected into mice and effect on tumor development measured. Cotargeting these two key kinases inhibited melanoma development more effectively than inhibiting each of these kinases alone [46, 151].